Vimarsana
Biggest News Aggregation in the World

Page 39 - Service Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Service Testing Today - Breaking & Trending Today

Bayer shares plunge by more than 20% after trial of potential blockbuster drug halted - Vimarsana News

Bayer shares plunge by more than 20% after trial of potential blockbuster drug halted

Bayer lost a fifth of its market value at one point Monday, after the German pharmaceutical and agricultural group said it had ended a late-stage test for...

MediciNova Shares Rise 14% After Positive Data for MN-166 Trial - Vimarsana News

MediciNova Shares Rise 14% After Positive Data for MN-166 Trial

By Chris Wack MediciNova shares were up 14% to $2.30 after the company reported positive data for its phase 2 clinical trial of MN-166 ibudilast in...

Vertex Shares Dip on Anxiety Over Pain Pill Trial - Vimarsana News

Vertex Shares Dip on Anxiety Over Pain Pill Trial

Vertex's COO said a trial of its new pain pill hadn't tested the drug against a placebo.

Medical Studies Are Too White. How Science Is Working to Get Better Data. - Vimarsana News

Medical Studies Are Too White. How Science Is Working to Get Better Data.

Efforts to diversify clinical trials aim to ensure devices, drugs and prevention work for all

Source: wsj.com
Ipsen, Genfit Drug Fights Liver Disease Progression, Phase-Three Trial Finds - Vimarsana News

Ipsen, Genfit Drug Fights Liver Disease Progression, Phase-Three Trial Finds

By David Sachs A drug to treat chronic liver disease developed by Ipsen and Genfit has gained a positive result in its phase-three trial, the companies said....